A carregar...
Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome
BACKGROUND: Tandutinib (MLN 518, Millennium Pharmaceuticals, Cambridge, MA) is an orally active multitargeted tyrosine kinase inhibitor that is currently under evaluation for the treatment of glioblastoma and has been used in the treatment of leukemia. In prior clinical and animal studies, a dose-de...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3034397/ https://ncbi.nlm.nih.gov/pubmed/21242491 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3182074a69 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|